Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Acer Therapeutics Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +7 vs. Q1 2022
- Shares held
- 1.56M
- +135.9K (+9.6%) vs. Q1 2022
- Total value
- $1.96M
- −$2.16M (−52.5%) vs. Q1 2022
- New holders
- 7
- 9 more added
- Sold out
- 0
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 30 | $3.40M |
| Q2 2023 | 27 | $2.32M |
| Q1 2023 | 26 | $3.48M |
| Q4 2022 | 32 | $6.14M |
| Q3 2022 | 28 | $2.22M |
| Q2 2022 | 28 | $1.96M |
| Q1 2022 | 21 | $4.12M |
| Q4 2021 | 24 | $3.35M |
| Q3 2021 | 25 | $3.91M |
| Q2 2021 | 30 | $4.47M |
| Q1 2021 | 30 | $5.15M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Acer Therapeutics Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 381 | $0 | 0.00% | −209−35.4% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Burleson & Company, LLC | 365 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 68 | $0 | 0.00% | +10+17.2% | Added |
| JFS Wealth Advisors, LLC | 24 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 33 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 179 | $226 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 922 | $1.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,771 | $2.00K | 0.00% | +1,771 | New |
| Tower Research Capital LLC (TRC) | 2,462 | $3.00K | 0.00% | +1,664+208.5% | Added |
| Morgan Stanley | 2,175 | $3.00K | 0.00% | +2,167+27,087.5% | Added |
| Simplex Trading, LLC | 2,691 | $3.00K | 0.00% | +2,449+1,012.0% | Added |
| Rockefeller Capital Management L.P. | 7,500 | $9.00K | 0.00% | +7,500 | New |
| Bank of New York Mellon Corp | 11,075 | $14.0K | 0.00% | −58−0.5% | Reduced |
| Virtu Financial LLC | 10,742 | $14.0K | 0.00% | +10,742 | New |
| Two Sigma Advisers, LP | 11,900 | $15.0K | 0.00% | +11,900 | New |
| Northern Trust Corp | 19,406 | $24.0K | 0.00% | +268+1.4% | Added |
| Hunter Associates Investment Management LLC | 19,000 | $24.0K | 0.01% | +19,000 | New |
| Citadel Advisors LLC | 22,574 | $28.0K | 0.00% | +22,574 | New |
| Copperwynd Financial, LLC | 23,255 | $29.0K | 0.02% | +23,255 | New |
| State Street Corp | 23,465 | $30.0K | 0.00% | −2,100−8.2% | Reduced |
| Renaissance Technologies LLC | 69,700 | $88.0K | 0.00% | +47,700+216.8% | Added |
| Geode Capital Management, LLC | 90,815 | $114.0K | 0.00% | +6,644+7.9% | Added |
| Goldman Sachs Group Inc | 93,381 | $118.0K | 0.00% | −1,852−1.9% | Reduced |
| BlackRock Inc. | 120,105 | $151.0K | 0.00% | +17,065+16.6% | Added |
| Vanguard Group Inc | 280,419 | $353.0K | 0.00% | +2,204+0.8% | Added |
| Nantahala Capital Management, LLC | 741,010 | $934.0K | 0.08% | −36,810−4.7% | Reduced |